bf/NASDAQ:IMNN_icon.jpeg

NASDAQ:IMNN

Imunon

  • Stock

USD

Last Close

0.82

08/11 21:00

Market Cap

12.60M

Beta: 2.08

Volume Today

273.98K

Avg: 57.47K

PE Ratio

−0.05

PFCF: −0.24

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
179.06K
-
156.23K
12.75%
145.00K
7.18%
86.98K
40.02%
42.38K
51.27%
1.17M
-
1.85M
58.62%
685.32K
63.04%
average payables
2.52M
-
2.47M
2.27%
3.16M
27.93%
4.10M
29.84%
4.39M
7.16%
3.22M
26.68%
2.94M
8.60%
2.55M
13.19%
2.40M
6.18%
5.46M
128.05%
5.95M
8.86%
average receivables
278.30K
-
291.92K
4.89%
118.38K
59.45%
15.37K
87.02%
29.22K
90.16%
61.37K
110.01%
44.84K
26.94%
10.68K
76.17%
54.42K
409.35%
118.89K
118.46%
64.47K
45.78%
book value per share
488.90
-
373.17
23.67%
196.26
47.41%
54.41
72.28%
52.52
3.47%
17.80
66.11%
10.00
43.80%
8.74
12.63%
10.28
17.65%
4.11
60.06%
1.48
63.95%
capex per share
-0.89
-
-7.64
757.09%
-1.05
86.23%
-0.51
51.96%
-0.08
84.98%
-0.12
55.42%
-0.24
103.17%
-0.01
96.26%
-0.06
540.51%
-0.04
34.71%
-0.05
33.21%
capex to depreciation
-0.17
-
-1.82
973.97%
-0.26
85.86%
-0.06
76.25%
-0.07
14.31%
-0.39
455.21%
-0.48
24.75%
-0.03
94.68%
-0.44
1,621.81%
-0.37
17.43%
-0.63
71.42%
capex to operating cash flow
0.01
-
0.03
418.65%
0.01
83.33%
0.00
35.21%
0.00
31.74%
0.02
746.74%
0.02
12.31%
0.00
92.91%
0.02
1,471.31%
0.01
39.72%
0.02
105.13%
capex to revenue
-0.11
-
-1.34
1,069.26%
-0.22
83.74%
-0.13
42.84%
-0.08
38.20%
-0.28
258.28%
-0.70
152.28%
-0.04
94.53%
-0.62
1,532.17%
-0.54
14.06%
cash per share
664.94
-
419.04
36.98%
193.17
53.90%
34.85
81.96%
47.53
36.37%
23.56
50.44%
10.21
56.65%
8.06
21.06%
9.12
13.17%
4.60
49.54%
1.74
62.30%
days of inventory on hand
days payables outstanding
1.78K
-
days sales outstanding
272.88
-
153.32
43.81%
19.51
87.27%
2.93
85.01%
39.74
1,258.28%
49.87
25.48%
15.60
68.72%
79.46
-
94.12
18.46%
debt to assets
0.11
-
0.15
32.66%
0.13
9.66%
0.08
36.89%
0.20
-
0.30
47.34%
0.17
44.25%
0.09
45.73%
0.14
59.07%
52.00
36,390.03%
debt to equity
0.16
-
0.30
86.04%
0.32
6.99%
0.38
20.32%
0.45
-
0.78
72.47%
0.33
57.25%
0.12
64.28%
0.21
79.72%
85.14
39,741.81%
dividend yield
earnings yield
-0.16
-
-0.59
278.12%
-0.54
9.46%
-2.83
428.09%
-0.95
66.51%
-0.48
49.47%
-0.45
5.83%
-0.95
109.85%
-0.47
50.12%
-3.72
687.92%
-3.17
14.77%
enterprise value
51.97M
-
40.06M
22.91%
39.07M
2.48%
7.72M
80.23%
10.06M
30.32%
20.86M
107.21%
41.79M
100.40%
11.71M
71.98%
31.01M
164.74%
4.42M
85.75%
1.94M
56.15%
enterprise value over ebitda
-3.63
-
-1.85
49.06%
-1.91
3.15%
-0.39
79.66%
-0.58
50.58%
-1.25
113.30%
-2.58
107.01%
-0.62
76.06%
-1.60
159.19%
-0.23
85.86%
-0.10
57.84%
ev to operating cash flow
-5.49
-
-1.88
65.80%
-1.88
0.04%
-0.42
77.59%
-0.60
43.93%
-2.96
389.72%
-2.06
30.34%
-0.75
63.65%
-1.91
154.87%
-0.19
90.01%
-0.10
46.67%
ev to sales
103.93
-
80.12
22.91%
78.13
2.48%
15.45
80.23%
20.13
30.32%
41.71
107.21%
83.59
100.40%
23.42
71.98%
62.01
164.74%
8.83
85.75%
free cash flow per share
-147.78
-
-250.39
69.43%
-201.59
19.49%
-149.20
25.99%
-32.80
78.01%
-6.13
81.33%
-14.16
131.15%
-7.34
48.14%
-3.05
58.50%
-3.28
7.51%
-2.15
34.28%
free cash flow yield
-0.18
-
-0.51
182.87%
-0.50
2.30%
-2.37
373.67%
-0.78
67.25%
-0.29
62.66%
-0.55
90.59%
-0.69
24.90%
-0.38
45.44%
-2.43
545.09%
-3.17
30.48%
graham net net
450.76
-
36.94
91.81%
-82.21
322.57%
-159.95
94.57%
6.68
104.18%
1.42
78.71%
-6.07
526.85%
-0.82
86.46%
5.99
827.88%
2.66
55.55%
0.79
70.24%
graham number
1.19K
-
1.56K
31.48%
977.16
37.36%
467.36
52.17%
217.74
53.41%
63.71
70.74%
51.05
19.88%
44.54
12.75%
29.75
33.19%
21.55
27.58%
8.48
60.66%
income quality
1.15
-
0.84
27.03%
0.93
10.73%
0.83
10.14%
0.82
2.12%
0.59
27.35%
1.20
102.88%
0.73
39.53%
0.78
7.45%
0.64
17.51%
0.97
51.27%
intangibles to total assets
0
-
0.42
Infinity%
0.57
35.96%
0.84
47.49%
0.48
42.00%
0.39
19.46%
0.47
20.89%
0.41
12.67%
0.18
56.17%
0
100%
0
interest coverage
-16.84
-
-18.63
10.65%
-15.36
17.56%
-29.80
93.99%
-201.28
575.47%
-29.58
85.30%
-14.76
50.11%
-14.30
3.08%
-37.71
163.65%
-5.45
85.55%
0.11
101.96%
interest debt per share
91.91
-
125.43
36.48%
75.16
40.08%
26.32
64.98%
0.18
99.31%
8.64
4,688.62%
8.74
1.20%
3.52
59.80%
1.33
62.31%
1.52
14.53%
104.22
6,767.50%
inventory turnover
invested capital
0.16
-
0.30
86.04%
0.32
6.99%
0.38
20.32%
0.45
-
0.78
72.47%
0.33
57.25%
0.12
64.28%
0.21
79.72%
85.14
39,741.81%
market cap
52.67M
-
43.04M
18.29%
41.88M
2.69%
7.79M
81.41%
21.51M
176.21%
24.79M
15.26%
37.33M
50.59%
22.68M
39.25%
43.96M
93.81%
9.64M
78.06%
6.15M
36.21%
net current asset value
29.62M
-
3.64M
87.72%
-8.39M
330.61%
-19.61M
133.82%
3.50M
117.86%
2.14M
38.98%
-7.48M
450.28%
-91.39K
98.78%
33.70M
36,971.48%
22.51M
33.20%
9.71M
56.86%
net debt to ebitda
0.05
-
0.14
178.25%
0.14
0.05%
0.00
97.66%
0.66
20,561.03%
0.24
64.59%
-0.28
217.03%
0.58
310.09%
0.67
15.60%
0.27
59.94%
0.21
22.48%
net income per share
-127.97
-
-289.83
126.48%
-216.24
25.39%
-178.42
17.49%
-40.12
77.51%
-10.14
74.73%
-11.58
14.20%
-10.09
12.87%
-3.83
62.06%
-5.03
31.32%
-2.16
57.07%
operating cash flow per share
-146.89
-
-242.75
65.25%
-200.54
17.39%
-148.70
25.85%
-32.73
77.99%
-6.01
81.65%
-13.92
131.70%
-7.33
47.31%
-2.99
59.24%
-3.24
8.33%
-2.10
35.06%
payables turnover
0.20
-
receivables turnover
1.34
-
2.38
77.98%
18.71
685.78%
124.75
566.89%
9.18
92.64%
7.32
20.30%
23.40
219.66%
4.59
-
3.88
15.58%
research and ddevelopement to revenue
18.73
-
29.94
59.86%
29.32
2.07%
29.25
0.25%
26.16
10.56%
23.73
9.28%
26.13
10.11%
22.69
13.17%
21.24
6.40%
23.47
10.50%
return on tangible assets
-0.18
-
-0.66
262.59%
-1.06
61.15%
-4.34
310.92%
-0.83
80.80%
-0.42
50.07%
-0.83
100.35%
-0.97
16.82%
-0.34
64.84%
-0.82
138.50%
-0.89
9.07%
revenue per share
7.75
-
5.68
26.70%
4.81
15.32%
4.05
15.96%
0.98
75.69%
0.43
56.62%
0.34
19.47%
0.23
31.66%
0.09
60.76%
0.07
24.02%
roe
-0.26
-
-0.78
196.72%
-1.10
41.86%
-3.28
197.64%
-0.76
76.70%
-0.57
25.44%
-1.16
103.19%
-1.15
0.27%
-0.37
67.75%
-1.22
228.83%
-1.46
19.09%
roic
-0.42
-
-0.60
41.96%
-0.83
39.05%
-2.37
184.10%
-0.76
67.99%
-0.37
51.04%
-0.68
82.60%
-0.66
3.08%
-0.31
52.51%
-0.67
113.93%
-0.02
97.43%
sales general and administrative to revenue
13.09
-
17.72
35.33%
13.37
24.53%
13.05
2.39%
11.78
9.76%
19.40
64.69%
16.00
17.52%
15.28
4.48%
21.78
42.48%
27.38
25.72%
shareholders equity per share
488.90
-
373.17
23.67%
196.26
47.41%
54.41
72.28%
52.52
3.47%
17.80
66.11%
10.00
43.80%
8.74
12.63%
10.28
17.65%
4.11
60.06%
1.48
63.95%
stock based compensation to revenue
2.47
-
5.17
109.25%
3.70
28.44%
3.02
18.31%
2.21
26.85%
9.21
316.60%
4.57
50.34%
3.70
19.03%
7.52
103.08%
5.35
28.90%
tangible asset value
31.52M
-
5.05M
83.99%
-7.39M
246.45%
-19.04M
157.57%
3.69M
119.36%
2.58M
30.01%
-3.49M
235.44%
3.16M
190.29%
42.43M
1,244.81%
29.33M
30.88%
13.39M
54.35%
tangible book value per share
488.90
-
57.38
88.26%
-71.17
224.02%
-154.04
116.45%
7.25
104.71%
2.20
69.64%
-2.40
209.07%
1.48
161.71%
7.82
427.74%
4.11
47.48%
1.48
63.95%
working capital
39.09M
-
27.42M
29.87%
10.93M
60.13%
-3.91M
135.78%
18.11M
563.10%
22.02M
21.60%
8.34M
62.13%
12.07M
44.73%
45.18M
274.24%
27.12M
39.97%
10.85M
59.99%

All numbers in USD (except ratios and percentages)